Short vs long antibiotic treatment for mild leptospirosis
Part of Infections clinical trials.
This study compares two antibiotic schedules (3 days vs 7 days) for adults with mild leptospirosis. It aims to find out if a shorter course works as well and is easier to tolerate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be being seen in one of the participating hospital centers
- Leptospirosis must be suspected and confirmed by quick blood test or PCR within 72 hours after starting antibiotics
- You must be able to join follow-up visits or check-ins at 7 days and 21 days after starting antibiotics
- You must sign a consent form
- You must not have features of severe illness (like breathing failure, kidney failure, very low blood pressure needing medicines, or stroke/meningitis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ways to prevent early and late complications of leptospirosis, a bacterial infection. It aims to offer treatments that may reduce the risk of serious problems like kidney failure or breathing difficulties.
This trial tests a structured set of hospital treatments (“care bundle”) for adults with suspected leptospirosis, a serious infection often linked to flood water exposure. It may help by improving how quickly and consistently key care steps are delivered in the hospital.
This study looks at how the body responds to leptospirosis infection to improve diagnosis and treatment. It is for people with fever and possible leptospirosis, as well as healthy volunteers.
This study examines how your immune system responds to leptospirosis (a bacterial infection) by analyzing blood samples. Researchers are testing a new approach to help your body fight the infection more effectively.
This study records information from people who have invasive (spreading) leptospirosis, a bacterial infection. The goal is to better understand how the disease presents and spreads, which can help improve future care.
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
Hear when a new Mild Leptospirosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.